Mesenchymal Cell News Volume 13.21 | Jun 1 2021

    0
    45







    2021-06-01 | MESCN 13.21


    Mesenchymal Cell News by STEMCELL Technologies
    Vol. 13.21 – 1 June, 2021
    TOP STORY

    Development of Selective Bispecific Wnt Mimetics for Bone Loss and Repair

    Scientists engineered bi-specific Wnt mimetics that targeted Frizzled and low-density lipoprotein receptor-related proteins and evaluated their effects on bone accrual in murine models.
    [Nature Communications]

    Full Article

    Register for the Virtual World Stem Cell Summit and Regenerative Medicine Essentials Course
    PUBLICATIONSRanked by the impact factor of the journal

    Notch-Wnt Signal Crosstalk Regulates Proliferation and Differentiation of Osteoprogenitor Cells during Intramembranous Bone Healing

    Investigators presented evidence that during intramembranous bone formation osteoprogenitor cell proliferation was controlled by Notch signaling, while differentiation is initiated by activation of canonical Wnt signaling.
    [npj Regenerative Medicine]

    Full Article

    The LINC01119-SOCS5 Axis as a Critical Theranostic in Triple-Negative Breast Cancer

    The authors focused on the emerging class of RNAs called long non-coding RNAs or lncRNAs and utilized an MSC-supported triple-negative breast cancer (TNBC) progression model to identify specific family members of functional relevance to TNBC pathogenesis.
    [npj Breast Cancer]

    Full Article

    Adipose Mesenchymal Stem Cell-Derived Exosomes Accelerate Skin Wound Healing via the lncRNA H19/miR-19b/SOX9 Axis

    Researchers determined the roles of exosomes derived from adipose mesenchymal stem cells (ADSC-Exos) in wound skin tissue repair. Flow cytometry and electron microscopy were carried out to identify ADSCs and ADSC-Exos, respectively.
    [Laboratory Investigation]

    Full Article

    Kinship of Conditionally Immortalized Cells Derived from Fetal Bone to Human Bone-Derived Mesenchymal Stroma Cells

    Investigators studied whether and to what extent the conditionally immortalized cell line hFOB 1.19 could serve as a surrogate model for bone-marrow-derived MSCs.
    [Scientific Reports]

    Full Article

    Wnt/ß-Catenin-Mediated p53 Suppression Is Indispensable for Osteogenesis of Mesenchymal Progenitor Cells

    Using conditional lineage-tracing mice, scientists demonstrated that chondrocytes gave rise to a sizable fraction of mesenchymal progenitor cells, which served as progenitors of chondrocyte-derived osteoblasts.
    [Cell Death & Disease]

    Full Article

    Phase II Study of Pazopanib with Oral Topotecan in Patients with Metastatic and Non-Resectable Soft Tissue and Bone Sarcomas

    This prospective, single-arm, Phase II study evaluated the efficacy of the combination of pazopanib with topotecan in patients with metastatic or unresectable non-adipocytic soft-tissue sarcoma
    [British Journal of Cancer]

    Abstract

    Intracerebral Administration of Autologous Mesenchymal Stem Cells as HSV-TK Gene Vehicle for Treatment of Glioblastoma Multiform: Safety and Feasibility Assessment

    The safety and feasibility of using bone marrow-derived MSCs in combination with prodrug for the treatment of patients with primary and secondary glioblastoma multiform were assessed.
    [Molecular Neurobiology]

    Abstract

    CD13 Is a Critical Regulator of Cell–Cell Fusion in Osteoclastogenesis

    Researchers showed that CD13-deficient mice presented a low bone density phenotype with increased numbers of osteoclasts per bone surface, but displayed a normal distribution of osteoclast progenitor populations in the bone marrow and periphery.
    [Scientific Reports]

    Full Article

    Explore virtual support and resources to stay productive and connected with your field.
    REVIEWS

    Autologous Stem Cell Therapy in Knee Osteoarthritis: A Systematic Review of Randomized Controlled Trials

    The authors review the evidence of autologous MSC therapy on pain, function and severity on imaging in knee osteoarthritis.
    [British Journal of Sports Medicine]

    Abstract

    Mesenchymal Stem Cells and Extracellular Vesicles for the Treatment of Pain: Current Status and Perspectives

    Investigators provide a detailed description of the functional properties of MSCs and extracellular vesicles and their potential clinical applications, with a special focus on pain treatment.
    [British Journal of Pharmacology]

    Abstract

    INDUSTRY AND POLICY NEWS

    Moleculin Commences Phase Ib/II Clinical Trial of Annamycin for the Treatment of Sarcoma Lung Metastases

    Moleculin Biotech, Inc. announced it has received clearance to initiate its Phase Ib/II clinical trial evaluating Annamycin for the treatment of soft tissue sarcoma lung metastases.
    [Moleculin Biotech, Inc.]

    Press Release

    FEATURED EVENT

    Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Lung Diseases

    July 12 – 15, 2021
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Fellowship – Center for Stem Cell and Organoid Medicine

    Cincinnati Children’s Hospital Medical Center – Cincinnati, Ohio, United States

    Postdoctoral Fellow – Bone Metastatic Prostate Cancer

    H. Lee Moffitt Cancer Center – Tampa, Florida, United States

    Postdoctoral Researcher – Regenerative Medicine

    National University of Ireland Galway – Galway, Ireland

    Research Associate – Primary Human Tumors

    Louisiana State University – New Orleans, Louisiana, United States

    Postdoctoral Fellow – Human Gene Regulation Map

    Broad Institute – Cambridge, Massachusetts, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Mesenchymal Cell News Twitter